A New Fully Liquid Presentation of MenACWY-CRM Conjugate Vaccine: Results from a Multicentre, Randomised, Controlled, Observer-Blind Study
The currently licensed quadrivalent MenACWY-CRM conjugate vaccine presentation consists of two vials (lyophilised MenA and liquid MenCWY) to be reconstituted before injection. A new fully liquid formulation in a single vial has been developed to further improve the vaccine presentation. Since the MenA structure is subject to hydrolytic degradation, this study was conducted to compare…